vs

Side-by-side financial comparison of Invesco (IVZ) and Kellanova (K). Click either name above to swap in a different company.

Kellanova is the larger business by last-quarter revenue ($3.3B vs $1.7B, roughly 1.9× Invesco). Kellanova runs the higher net margin — 9.5% vs -58.9%, a 68.3% gap on every dollar of revenue. On growth, Invesco posted the faster year-over-year revenue change (6.2% vs 0.8%). Invesco produced more free cash flow last quarter ($432.2M vs $359.0M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs -9.0%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Kellanova, formerly known as the Kellogg Company, is an American multinational food manufacturing company owned by Mars Inc. headquartered in Chicago, Illinois. The renaming took effect on October 2, 2023, and the company's North American cereal operations were spun off to form the WK Kellogg Co at the same time.

IVZ vs K — Head-to-Head

Bigger by revenue
K
K
1.9× larger
K
$3.3B
$1.7B
IVZ
Growing faster (revenue YoY)
IVZ
IVZ
+5.4% gap
IVZ
6.2%
0.8%
K
Higher net margin
K
K
68.3% more per $
K
9.5%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$73.2M more FCF
IVZ
$432.2M
$359.0M
K
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
-9.0%
K

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IVZ
IVZ
K
K
Revenue
$1.7B
$3.3B
Net Profit
$-995.9M
$309.0M
Gross Margin
33.3%
Operating Margin
-86.2%
13.9%
Net Margin
-58.9%
9.5%
Revenue YoY
6.2%
0.8%
Net Profit YoY
-575.8%
-15.8%
EPS (diluted)
$-2.61
$0.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
K
K
Q4 25
$1.7B
Q3 25
$1.6B
$3.3B
Q2 25
$1.5B
$3.2B
Q1 25
$1.5B
$3.1B
Q4 24
$1.6B
$3.1B
Q3 24
$1.5B
$3.2B
Q2 24
$1.5B
$3.2B
Q1 24
$1.5B
$3.2B
Net Profit
IVZ
IVZ
K
K
Q4 25
$-995.9M
Q3 25
$356.4M
$309.0M
Q2 25
$197.4M
$299.0M
Q1 25
$171.1M
$304.0M
Q4 24
$209.3M
$365.0M
Q3 24
$55.0M
$367.0M
Q2 24
$132.2M
$344.0M
Q1 24
$141.5M
$267.0M
Gross Margin
IVZ
IVZ
K
K
Q4 25
Q3 25
33.3%
Q2 25
34.0%
Q1 25
34.3%
Q4 24
37.7%
Q3 24
36.4%
Q2 24
36.4%
Q1 24
32.2%
Operating Margin
IVZ
IVZ
K
K
Q4 25
-86.2%
Q3 25
16.5%
13.9%
Q2 25
14.1%
13.7%
Q1 25
18.1%
13.9%
Q4 24
19.6%
17.0%
Q3 24
6.6%
14.1%
Q2 24
13.9%
15.4%
Q1 24
14.4%
12.3%
Net Margin
IVZ
IVZ
K
K
Q4 25
-58.9%
Q3 25
21.7%
9.5%
Q2 25
13.0%
9.3%
Q1 25
11.2%
9.9%
Q4 24
13.1%
11.7%
Q3 24
3.6%
11.4%
Q2 24
8.9%
10.8%
Q1 24
9.6%
8.3%
EPS (diluted)
IVZ
IVZ
K
K
Q4 25
$-2.61
Q3 25
$0.66
$0.88
Q2 25
$-0.03
$0.85
Q1 25
$0.38
$0.87
Q4 24
$0.46
$1.05
Q3 24
$0.12
$1.05
Q2 24
$0.29
$1.00
Q1 24
$0.31
$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
K
K
Cash + ST InvestmentsLiquidity on hand
$1.0B
$240.0M
Total DebtLower is stronger
$1.8B
$4.3B
Stockholders' EquityBook value
$12.2B
$4.2B
Total Assets
$27.1B
$15.6B
Debt / EquityLower = less leverage
0.15×
1.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
K
K
Q4 25
$1.0B
Q3 25
$973.1M
$240.0M
Q2 25
$922.7M
$354.0M
Q1 25
$821.7M
$330.0M
Q4 24
$986.5M
$694.0M
Q3 24
$1.0B
$569.0M
Q2 24
$878.5M
$272.0M
Q1 24
$895.7M
$242.0M
Total Debt
IVZ
IVZ
K
K
Q4 25
$1.8B
Q3 25
$1.6B
$4.3B
Q2 25
$1.9B
$4.3B
Q1 25
$964.8M
$5.0B
Q4 24
$890.6M
$5.0B
Q3 24
$890.3M
$5.1B
Q2 24
$890.1M
$5.0B
Q1 24
$1.3B
$4.4B
Stockholders' Equity
IVZ
IVZ
K
K
Q4 25
$12.2B
Q3 25
$14.0B
$4.2B
Q2 25
$13.9B
$4.1B
Q1 25
$14.7B
$3.9B
Q4 24
$14.6B
$3.8B
Q3 24
$14.8B
$3.6B
Q2 24
$14.6B
$3.3B
Q1 24
$14.6B
$3.2B
Total Assets
IVZ
IVZ
K
K
Q4 25
$27.1B
Q3 25
$28.4B
$15.6B
Q2 25
$28.5B
$15.9B
Q1 25
$28.1B
$15.5B
Q4 24
$27.0B
$15.6B
Q3 24
$27.5B
$15.8B
Q2 24
$27.2B
$15.3B
Q1 24
$28.1B
$15.3B
Debt / Equity
IVZ
IVZ
K
K
Q4 25
0.15×
Q3 25
0.12×
1.02×
Q2 25
0.14×
1.05×
Q1 25
0.07×
1.28×
Q4 24
0.06×
1.32×
Q3 24
0.06×
1.40×
Q2 24
0.06×
1.51×
Q1 24
0.09×
1.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
K
K
Operating Cash FlowLast quarter
$455.8M
$503.0M
Free Cash FlowOCF − Capex
$432.2M
$359.0M
FCF MarginFCF / Revenue
25.5%
11.0%
Capex IntensityCapex / Revenue
1.4%
4.4%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$599.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
K
K
Q4 25
$455.8M
Q3 25
$606.2M
$503.0M
Q2 25
$547.9M
$169.0M
Q1 25
$-84.6M
$116.0M
Q4 24
$316.9M
$467.0M
Q3 24
$438.4M
$553.0M
Q2 24
$489.1M
$376.0M
Q1 24
$-54.4M
$364.0M
Free Cash Flow
IVZ
IVZ
K
K
Q4 25
$432.2M
Q3 25
$586.4M
$359.0M
Q2 25
$530.4M
$21.0M
Q1 25
$-108.0M
$-60.0M
Q4 24
$309.9M
$279.0M
Q3 24
$410.0M
$410.0M
Q2 24
$462.4M
$234.0M
Q1 24
$-75.4M
$209.0M
FCF Margin
IVZ
IVZ
K
K
Q4 25
25.5%
Q3 25
35.7%
11.0%
Q2 25
35.0%
0.7%
Q1 25
-7.1%
-1.9%
Q4 24
19.5%
8.9%
Q3 24
27.1%
12.7%
Q2 24
31.2%
7.3%
Q1 24
-5.1%
6.5%
Capex Intensity
IVZ
IVZ
K
K
Q4 25
1.4%
Q3 25
1.2%
4.4%
Q2 25
1.2%
4.6%
Q1 25
1.5%
5.7%
Q4 24
0.4%
6.0%
Q3 24
1.9%
4.4%
Q2 24
1.8%
4.4%
Q1 24
1.4%
4.8%
Cash Conversion
IVZ
IVZ
K
K
Q4 25
Q3 25
1.70×
1.63×
Q2 25
2.78×
0.57×
Q1 25
-0.49×
0.38×
Q4 24
1.51×
1.28×
Q3 24
7.97×
1.51×
Q2 24
3.70×
1.09×
Q1 24
-0.38×
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

K
K

Retail Channel Snacks$2.0B62%
Retail Channel Cereal$678.0M21%
Noodlesand Other$280.0M9%
Frozen And Specialty Channels$275.0M8%

Related Comparisons